Screening for alcohol and drug use during pregnancy.
The use of alcohol and other substances is not infrequent during pregnancy and may be associated with adverse effects on pregnancy outcome. Many pregnant women may continue these practices throughout pregnancy and even after delivery, unless they are recognized and assessed. Screening may be one way to achieve consistent and early identification. Prenatal health care providers may wish to screen all pregnant patients for their use of alcohol and other drugs using an approach that works best in their setting. A positive screen is an opportunity for the clinician and patient to discuss health practices and behaviors.
Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Department of Psychiatry, VA Boston Healthcare System, 940 Belmont Street, Brockton, MA 02301, USA. Electronic address: Grace.Chang2@va.gov.
Grace
G
Chang
D015415:Biomarkers / Q000378:metabolism; D005260:Female; D006801:Humans; D008403:Mass Screening; D011247:Pregnancy; D011248:Pregnancy Complications; D037841:Pregnant People / Q000523:psychology; D011295:Prenatal Care / Q000379:methods*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000379:methods; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000517:prevention & control / Q000523:psychology; D011795:Surveys and Questionnaires; D014342:Truth Disclosure; D014481:United States / Q000453:epidemiology
D015415:Biomarkers
Biomarkers; Questionnaires; Sensitivity; Specificity